Association of Biologic False-Positive Reactions for Syphilis with Human Immunodeficiency Virus Infection

Anne Marie Rompalo, Robert O. Cannon, Thomas C Quinn, Edward W. Hook

Research output: Contribution to journalArticle

Abstract

The prevalence of biologic false-positive (BFP) reactions for syphilis (reactive rapid plasma reagin [RPR] test, nonreactive fluorescent treponemal antibody absorption [FTA-ABS] test) among patients attending two sexually transmitted disease (STD) clinics was evaluated to assess relationships between BFP reactions and human immunodeficiency virus (HIV) infection. Among 4863 patients, 357 (7.3%) had serologic evidence of syphilis and 4.9% had HIV infection. Only 40 patients (0.8% of total patients, 11% of those with reactive RPR tests) had BFP serologic tests for syphilis. There were no demographic differences between true syphilis and BFP patients as to sex, age, or intravenous drug use. BFP patients tended to have lower RPR titers (≤1:4) than did true syphilis patients. After excluding 317 patients with reactive FTA-ABS tests, BFP RPR tests were seen in 6 (4%) of 159 HIV-seropositive patients and 34 (0.8%) of 4387 HIV-seronegative patients (odds ratio, 5.0; 95% confidence interval, 1.9-12.7). Although more common among HIV-infected than HIV-uninfected patients, BFP reactions are relatively rare among STD clinic patients, and 89% of patients with reactive RPR or VDRL serologic tests for syphilis had current or prior syphilis infection. The RPR test remains useful for guiding decisions regarding therapy for syphilis.

Original languageEnglish (US)
Pages (from-to)1124-1126
Number of pages3
JournalJournal of Infectious Diseases
Volume165
Issue number6
DOIs
StatePublished - 1992

Fingerprint

False Positive Reactions
Virus Diseases
Syphilis
HIV
Reagins
Fluorescent Treponemal Antibody-Absorption Test
Serologic Tests
Sexually Transmitted Diseases

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Association of Biologic False-Positive Reactions for Syphilis with Human Immunodeficiency Virus Infection. / Rompalo, Anne Marie; Cannon, Robert O.; Quinn, Thomas C; Hook, Edward W.

In: Journal of Infectious Diseases, Vol. 165, No. 6, 1992, p. 1124-1126.

Research output: Contribution to journalArticle

@article{5f688032450046ecaf7d4d80f3af751a,
title = "Association of Biologic False-Positive Reactions for Syphilis with Human Immunodeficiency Virus Infection",
abstract = "The prevalence of biologic false-positive (BFP) reactions for syphilis (reactive rapid plasma reagin [RPR] test, nonreactive fluorescent treponemal antibody absorption [FTA-ABS] test) among patients attending two sexually transmitted disease (STD) clinics was evaluated to assess relationships between BFP reactions and human immunodeficiency virus (HIV) infection. Among 4863 patients, 357 (7.3{\%}) had serologic evidence of syphilis and 4.9{\%} had HIV infection. Only 40 patients (0.8{\%} of total patients, 11{\%} of those with reactive RPR tests) had BFP serologic tests for syphilis. There were no demographic differences between true syphilis and BFP patients as to sex, age, or intravenous drug use. BFP patients tended to have lower RPR titers (≤1:4) than did true syphilis patients. After excluding 317 patients with reactive FTA-ABS tests, BFP RPR tests were seen in 6 (4{\%}) of 159 HIV-seropositive patients and 34 (0.8{\%}) of 4387 HIV-seronegative patients (odds ratio, 5.0; 95{\%} confidence interval, 1.9-12.7). Although more common among HIV-infected than HIV-uninfected patients, BFP reactions are relatively rare among STD clinic patients, and 89{\%} of patients with reactive RPR or VDRL serologic tests for syphilis had current or prior syphilis infection. The RPR test remains useful for guiding decisions regarding therapy for syphilis.",
author = "Rompalo, {Anne Marie} and Cannon, {Robert O.} and Quinn, {Thomas C} and Hook, {Edward W.}",
year = "1992",
doi = "10.1093/infdis/165.6.1124",
language = "English (US)",
volume = "165",
pages = "1124--1126",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Association of Biologic False-Positive Reactions for Syphilis with Human Immunodeficiency Virus Infection

AU - Rompalo, Anne Marie

AU - Cannon, Robert O.

AU - Quinn, Thomas C

AU - Hook, Edward W.

PY - 1992

Y1 - 1992

N2 - The prevalence of biologic false-positive (BFP) reactions for syphilis (reactive rapid plasma reagin [RPR] test, nonreactive fluorescent treponemal antibody absorption [FTA-ABS] test) among patients attending two sexually transmitted disease (STD) clinics was evaluated to assess relationships between BFP reactions and human immunodeficiency virus (HIV) infection. Among 4863 patients, 357 (7.3%) had serologic evidence of syphilis and 4.9% had HIV infection. Only 40 patients (0.8% of total patients, 11% of those with reactive RPR tests) had BFP serologic tests for syphilis. There were no demographic differences between true syphilis and BFP patients as to sex, age, or intravenous drug use. BFP patients tended to have lower RPR titers (≤1:4) than did true syphilis patients. After excluding 317 patients with reactive FTA-ABS tests, BFP RPR tests were seen in 6 (4%) of 159 HIV-seropositive patients and 34 (0.8%) of 4387 HIV-seronegative patients (odds ratio, 5.0; 95% confidence interval, 1.9-12.7). Although more common among HIV-infected than HIV-uninfected patients, BFP reactions are relatively rare among STD clinic patients, and 89% of patients with reactive RPR or VDRL serologic tests for syphilis had current or prior syphilis infection. The RPR test remains useful for guiding decisions regarding therapy for syphilis.

AB - The prevalence of biologic false-positive (BFP) reactions for syphilis (reactive rapid plasma reagin [RPR] test, nonreactive fluorescent treponemal antibody absorption [FTA-ABS] test) among patients attending two sexually transmitted disease (STD) clinics was evaluated to assess relationships between BFP reactions and human immunodeficiency virus (HIV) infection. Among 4863 patients, 357 (7.3%) had serologic evidence of syphilis and 4.9% had HIV infection. Only 40 patients (0.8% of total patients, 11% of those with reactive RPR tests) had BFP serologic tests for syphilis. There were no demographic differences between true syphilis and BFP patients as to sex, age, or intravenous drug use. BFP patients tended to have lower RPR titers (≤1:4) than did true syphilis patients. After excluding 317 patients with reactive FTA-ABS tests, BFP RPR tests were seen in 6 (4%) of 159 HIV-seropositive patients and 34 (0.8%) of 4387 HIV-seronegative patients (odds ratio, 5.0; 95% confidence interval, 1.9-12.7). Although more common among HIV-infected than HIV-uninfected patients, BFP reactions are relatively rare among STD clinic patients, and 89% of patients with reactive RPR or VDRL serologic tests for syphilis had current or prior syphilis infection. The RPR test remains useful for guiding decisions regarding therapy for syphilis.

UR - http://www.scopus.com/inward/record.url?scp=0026596517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026596517&partnerID=8YFLogxK

U2 - 10.1093/infdis/165.6.1124

DO - 10.1093/infdis/165.6.1124

M3 - Article

C2 - 1583332

AN - SCOPUS:0026596517

VL - 165

SP - 1124

EP - 1126

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 6

ER -